Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02132676 · ClinicalTrials.gov registry record
Shared Health Appointments and Reciprocal Enhanced Support
A clinical trial of Diabetes Insipidus, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 1,536
- Enrollment target
- 5
- Study locations
NCT02132676 is a study of Diabetes Insipidus that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,536 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT02132676, a study of Diabetes Insipidus, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 1,536 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to evaluate the effectiveness of a peer-to-peer program (P2P) in addition to Shared Medical Appointments (SMAs) compared to SMAs alone for the treatment of diabetes in five VA health systems, and to study the implementation process in order to gather information required to disseminate the program more broadly in the VHA system.
Conditions Studied
Study Locations (5)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
- VA Northern California Health Care System, Mather, CA - Sacramento
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Michigan
- VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor
Rhode Island
- Providence VA Medical Center, Providence, RI - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,536 participants |
| Start Date | 2016-04-25 |
| Est. Completion | 2019-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02132676
The ClinicalTrials.gov registry entry for NCT02132676 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,536 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Insipidus appearing as the primary indexed condition, and to 0 interventions.
NCT02132676 reports 5 study locations spanning 4 distinct geographic areas - top geographies include California, Connecticut, Michigan.
Frequently Asked Questions
What is clinical trial NCT02132676 about?
NCT02132676 is a clinical study titled "Shared Health Appointments and Reciprocal Enhanced Support". The purpose of this study is to evaluate the effectiveness of a peer-to-peer program (P2P) in addition to Shared Medical Appointments (SMAs) compared to SMAs alone for the treatment of diabetes in five VA health systems, and to study the implementation process in order to gather information required...
What is the current status of trial NCT02132676?
This trial is currently completed. The enrollment target is 1,536 participants. The study started on 2016-04-25. Estimated completion is 2019-07-30.
What conditions does trial NCT02132676 study?
This clinical trial studies the following conditions: Diabetes Insipidus.
Who is sponsoring clinical trial NCT02132676?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02132676 being conducted?
This trial has 5 study locations across California, Connecticut, Michigan, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Insipidus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.